This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher (TMO) to Open New NanoPort Facility in Taiwan
by Zacks Equity Research
Thermo Fisher (TMO) announces the opening of NanoPort, the company???s first electron microscopy demo center in Taiwan, strategically located in the region???s semiconductor manufacturing hub.
Thermo Fisher (TMO) Strategic Buyouts Aid Amid Macro Issues
by Zacks Equity Research
Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
by Zacks Equity Research
Olink's (OLK) buyout by Thermo Fisher gets CMA's approval, signaling regulatory confidence in the merger's compliance with competition laws.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands
by Zacks Equity Research
Thermo Fisher Scientific, Eaton, Palo Alto, Keurig Dr Pepper and Yum! Brands are included in this Analyst Blog.
Top Analyst Reports for Thermo Fisher, Eaton & Palo Alto
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Eaton Corporation plc (ETN) and Palo Alto Networks, Inc. (PANW).
Thermo Fisher (TMO) Brings Biobased, Sustainable Films for BPCs
by Zacks Equity Research
Thermo Fisher (TMO) has launched biobased solutions to help reduce the climate impact on the manufacturing of therapies.
Thermo Fisher (TMO) Expands Central Lab Footprint in Kentucky
by Zacks Equity Research
Thermo Fisher (TMO) announces expansion of its central laboratory operations in Kentucky. The new space in Covington will be in addition to its existing central lab in Highland Heights.
Thermo Fisher's (TMO) New Launch Speeds Up pDNA Purification
by Zacks Equity Research
Thermo Fisher (TMO) introduces the Thermo Scientific KingFisher PlasmidPro, the fully automated maxi-scale pDNA purification system.
Thermo Fisher (TMO) Unveils New Research Laboratory in WI
by Zacks Equity Research
Thermo Fisher (TMO) announces a new 72,500-square-foot clinical research laboratory building at its good manufacturing practices lab in Middleton, WI
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
by Zacks Equity Research
Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
Thermo Fisher's (TMO) New Launch Supports Full Lab Automation
by Zacks Equity Research
Thermo Fisher's (TMO) first-of-its-kind innovation for CO2 incubators supports emerging automated cell therapy production processes.
Steris (STE) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Thermo Fisher (TMO) Should be in Your Portfolio
by Zacks Equity Research
Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).
Agilent (A) Boosts Reach to Lab Researchers With New Devices
by Zacks Equity Research
Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell.
Waters (WAT) Expands Mass Spectrometer Portfolio With Xevo MRT
by Zacks Equity Research
Waters (WAT) boosts MS offerings with the launch of Xevo MRT, strengthening its Waters operating segment's portfolio.
Thermo Fisher (TMO) Up 2.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array
by Zacks Equity Research
Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.
Don't Overlook Thermo Fisher (TMO) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Review Thermo Fisher's (TMO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom
by Zacks Equity Research
Thermo Fisher Scientific, Disney, Southern Copper, Tractor Supply and Omnicom are included in this Analyst Blog.
Top Research Reports for Thermo Fisher Scientific, Walt Disney & Southern Copper
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), The Walt Disney Company (DIS) and Southern Copper Corporation (SCCO).
Company News for Apr 25, 2024
by Zacks Equity Research
Companies in The News Are: T,TMO,GD,ETR
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
by Zacks Equity Research
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
Durable Goods Orders Came In Line With Expectations
by Zacks Equity Research
Durable Goods Orders Came In Line With Expectations
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
by Mark Vickery
Boeing posted a slimmer loss per share while Thermo Fisher outperformed. Durable Goods performed as expected.
Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.